MENU
MBX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
MBX Biosciences (MBX) Ownership - Who owns MBX Biosciences?
MBX Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
247.67M
P/E Ratio
N/A
Total Cash
277.06M
Projected Growth
N/A
Total Debt
210K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
8.29
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
MBX
Capitalization
248M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
277M
Total Cash/Share
8.29
Total Debt
210K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
271M
P/B Ratio
1.01
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
25.75
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-56.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.54
Shares Held By Institutions
525M
Shares Outstanding - Current
33.4M
Total Liabilities
11M
Total Volume MTD
N/A
Value
1
Gain YTD
-57.895
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information